Publication Date
| In 2025 | 0 |
| Since 2024 | 0 |
| Since 2021 (last 5 years) | 0 |
| Since 2016 (last 10 years) | 0 |
| Since 2006 (last 20 years) | 1 |
Descriptor
| Adults | 1 |
| Age Differences | 1 |
| Attention Deficit Disorders | 1 |
| Drug Abuse | 1 |
| Drug Therapy | 1 |
| Educational Attainment | 1 |
| Outcomes of Treatment | 1 |
| Stimulants | 1 |
| Substance Abuse | 1 |
| Symptoms (Individual… | 1 |
Author
| Brady, Kathleen T. | 1 |
| Carter, Rickey E. | 1 |
| Hartwell, Karen J. | 1 |
| McRae-Clark, Aimee L. | 1 |
| White, Kathleen | 1 |
Publication Type
| Journal Articles | 1 |
| Reports - Research | 1 |
Education Level
Audience
Location
Laws, Policies, & Programs
Assessments and Surveys
| Conners Rating Scales | 1 |
What Works Clearinghouse Rating
Peer reviewed
Direct linkMcRae-Clark, Aimee L.; Brady, Kathleen T.; Hartwell, Karen J.; White, Kathleen; Carter, Rickey E. – Journal of Attention Disorders, 2011
Objective: This 8-week, open-label trial assessed the efficacy of methylphenidate transdermal system (MTS) in 14 adult individuals diagnosed with ADHD and with a history of stimulant misuse, abuse, or dependence. Method: The primary efficacy endpoint was the Wender-Reimherr Adult ADHD Scale (WRAADS), and secondary efficacy endpoints included the…
Descriptors: Stimulants, Substance Abuse, Attention Deficit Disorders, Drug Therapy
